Area of research
Pediatrics, Perinatology and Child Health · Public Health, Environmental and Occupational Health
Research interest
Research interests include Medicine, Internal medicine, Oncology, Hazard ratio, Transplantation, and Cardiomyopathy.
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma
Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality
Self‐rated health is an independent predictor of subsequent late mortality after blood or marrow transplantation: A Blood or Marrow Transplant Survivor Study report
Poverty and Relapse Risk in Children with Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL03N1 Report
Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors
Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation Recipients
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline‐Induced Cardiomyopathy – A COG‐ALTE03N1 Report
Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors
Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report
Genome-Wide Association Study Identifies <i>ROBO2</i> as a Novel Susceptibility Gene for Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors
Severe, life‐threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model
Association of <i>GSTM1</i> null variant with anthracycline‐related cardiomyopathy after childhood cancer—A Children's Oncology Group ALTE03N1 report
Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia
Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report
A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer
Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report
Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1
Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood
Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)
Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report
Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children’s Oncology Group study
<i>CELF4</i> Variant and Anthracycline-Related Cardiomyopathy: A Children’s Oncology Group Genome-Wide Association Study
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia
6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study